51st week of 2020 patent applcation highlights part 22 |
Patent application number | Title | Published |
20200392128 | NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS | 2020-12-17 |
20200392129 | Crystal Forms of Demethyleneberberine Hydrochloride and Preparation Method Therefor | 2020-12-17 |
20200392130 | SUBSTITUTED PYRAZOLO[4,3-b]PYRIDINES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | 2020-12-17 |
20200392131 | COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS | 2020-12-17 |
20200392132 | Tetrahydro-Pyrido-Pyrimidine Derivatives | 2020-12-17 |
20200392133 | AZAINDOLE DERIVATIVES AS RHO- KINASE INHIBITORS | 2020-12-17 |
20200392134 | METHOD FOR PURIFYING 2-[[2-[[[3-(4-CHLOROPHENYL)-8-METHYL-8-AZABICYCLO-[3.2.1]-OCT-2-YL]METHYL- ](2-MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOL-[1R-(EXO-EXO)]TRIHYDROCHLO- RIDE | 2020-12-17 |
20200392135 | ORGANIC COMPOUNDS | 2020-12-17 |
20200392136 | INHIBITING THE TRANSIENT RECEPTOR POTENTIAL A1 ION CHANNEL | 2020-12-17 |
20200392137 | TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS HAVING HETEROATOM-LINKED AROMATIC MOIETIES, CONJUGATES THEREOF, AND METHODS AND USES THEREFOR | 2020-12-17 |
20200392138 | PESTICIDALLY ACTIVE MESOIONIC HETEROCYCLIC COMPOUNDS | 2020-12-17 |
20200392139 | PYRROLO[2,3-D]PYRIMIDINONE COMPOUNDS AS CDK2 INHIBITORS | 2020-12-17 |
20200392140 | OPTIONALLY FUSED HETEROCYCLYL- SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES | 2020-12-17 |
20200392141 | PROCESS FOR PREPARING BETA 3 AGONISTS AND INTERMEDIATES | 2020-12-17 |
20200392142 | CDK2/4/6 Inhibitors | 2020-12-17 |
20200392143 | HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS | 2020-12-17 |
20200392144 | PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA | 2020-12-17 |
20200392145 | PROCESS | 2020-12-17 |
20200392146 | NITROGENOUS TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE | 2020-12-17 |
20200392147 | AMIDINO- AND AMINO-ROCAGLATES AS NOVEL TRANSLATION INHIBITORS AND ANTICANCER AGENTS | 2020-12-17 |
20200392148 | CHEMOSENSOR AND A METHOD OF DETECTING PALLADIUM IONS | 2020-12-17 |
20200392149 | SUBSTITUTED PYRROLIDINE COMPOUND AND USE THEREOF | 2020-12-17 |
20200392150 | Diaryl-B-Lactam Compound and Preparation Method and Pharmaceutical Use Thereof | 2020-12-17 |
20200392151 | COMBINATION OF A MCL-1 INHIBITOR AND A STANDARD OF CARE TREATMENT FOR HEMATOLOGIC CANCERS, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2020-12-17 |
20200392152 | COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 2020-12-17 |
20200392153 | SUBSTITUTED ENEOXINDOLES AND USES THEREOF | 2020-12-17 |
20200392154 | PYRIDINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | 2020-12-17 |
20200392155 | PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS | 2020-12-17 |
20200392156 | AMINOPYRIMIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS | 2020-12-17 |
20200392157 | CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF | 2020-12-17 |
20200392158 | INHIBITORS OF LEUCINE RICH REPEAT KINASE 2 | 2020-12-17 |
20200392159 | NOVEL RAPAMYCIN DERIVATIVES | 2020-12-17 |
20200392160 | MACROCYCLIC COMPOUNDS FOR TREATING DISEASE | 2020-12-17 |
20200392161 | SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF | 2020-12-17 |
20200392162 | CHROMENOPYRIMIDINE DERIVATIVES AS PHOSPHATIDYLINSITOL PHOSPHATE KINASE INHIBITORS | 2020-12-17 |
20200392163 | METHOD OF 4-BORONOPHENYLALANINE PRODUCTION | 2020-12-17 |
20200392164 | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2020-12-17 |
20200392165 | COMPOUND, DISPLAY PANEL AND DISPLAY APPARATUS | 2020-12-17 |
20200392166 | BIO-BASED REACTIVE PLASTICIZER AND ADHESIVES AND SEALANTS CONTAINING THEM | 2020-12-17 |
20200392167 | DIVALENT PHOSPHAZENIUM SALT AND POLYALKYLENE OXIDE COMPOSITION CONTAINING THE SAME, AS WELL AS POLYURETHANE-FORMING COMPOSITION CONTAINING THE POLYALKYLENE OXIDE COMPOSITION | 2020-12-17 |
20200392168 | OXAZOLIDINONE-QUINOLONE HYBRID ANTIBACTERIAL FOR THE PARENTERAL TREATMENT OF PROPHYLAXIS OF BACTERIAL DISEASES | 2020-12-17 |
20200392169 | ACYCLIC ANTIVIRALS | 2020-12-17 |
20200392170 | COT MODULATORS AND METHODS OF USE THEREOF | 2020-12-17 |
20200392171 | METAL COMPLEXES HAVING TRIAZENIDO LIGANDS AND USES THEREOF FOR DEPOSITING METALS FROM THE GAS PHASE | 2020-12-17 |
20200392172 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2020-12-17 |
20200392173 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | 2020-12-17 |
20200392174 | NOVEL INHIBITORS OF BACTERIAL GLUTAMINYL CYCLASES FOR USE IN THE TREATMENT OF PERIODONTAL AND RELATED DISEASES | 2020-12-17 |
20200392175 | PROCESS FOR THE MANUFACTURE OF MALTOSYL-ISOMALTOOLIGOSACCHARIDES (MIMO) | 2020-12-17 |
20200392176 | SOLID FORMS OF (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3- ,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CA- RBOXYLIC ACID | 2020-12-17 |
20200392177 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2020-12-17 |
20200392178 | PROTEIN-TARGETED DRUG COMPOUND IDENTIFICATION | 2020-12-17 |
20200392179 | Chromatography Medium | 2020-12-17 |
20200392180 | PEPTIDE COMPOSITIONS FOR SLOWING DEGRADATION OF VITAMIN MINERAL SUPPLEMENTS, FOODS, PHARMACEUTICAL AND COSMETICS | 2020-12-17 |
20200392181 | PEPTIDE COMPOSITIONS AND RELATED METHODS | 2020-12-17 |
20200392182 | RAPADOCINS, INHIBITORS OF EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 AND USES THEREOF | 2020-12-17 |
20200392183 | IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF | 2020-12-17 |
20200392184 | PEPTIDE COMPOUNDS AND PEPTIDE CONJUGATES FOR THE TREATMENT OF CANCER THROUGH RECEPTOR-MEDIATED CHEMOTHERAPY | 2020-12-17 |
20200392185 | COMPOSITIONS AND METHODS OF INHIBITING THE BINDING OF PLASMA IGG AUTOANTIBODIES TO SEROTONIN 2A RECEPTOR | 2020-12-17 |
20200392186 | COMPOUNDS AND METHODS FOR TREATING TIGHT JUNCTION PERMEABILITY | 2020-12-17 |
20200392187 | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus F proteins and their use | 2020-12-17 |
20200392188 | MARBURG VIRUS VACCINE WITH HUMAN REPLICATION-DEFICIENT ADENOVIRUS AS VECTOR | 2020-12-17 |
20200392189 | MICROORGANISMS WITH INCREASED PHOTOSYNTHETIC CAPACITY | 2020-12-17 |
20200392190 | FLAGELLIN-BASED AGENTS AND USES INCLUDING EFFECTIVE VACCINATION | 2020-12-17 |
20200392191 | OMPG VARIANTS | 2020-12-17 |
20200392192 | ANTI-VIRAL PROTEINS | 2020-12-17 |
20200392193 | FUSION PROTEIN | 2020-12-17 |
20200392194 | B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS | 2020-12-17 |
20200392195 | GLUCAGON-LIKE PEPTIDE-2 COMPOSITIONS AND METHODS OF MAKING AND USING SAME | 2020-12-17 |
20200392196 | LONG-ACTING CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS | 2020-12-17 |
20200392197 | ANTIBODY PEPTIDE CONJUGATES THAT HAVE AGONIST ACTIVITY AT BOTH THE GLUCAGON AND GLUCAGON-LIKE PEPTIDE 1 RECEPTORS | 2020-12-17 |
20200392198 | PEPTIDE DUAL AGONISTS OF GIPR AND GLP2R | 2020-12-17 |
20200392199 | METHODS OF TREATING CANCER | 2020-12-17 |
20200392200 | Compositions and Methods for Treating Cancer with DuoCARs | 2020-12-17 |
20200392201 | Antigen Discovery for T Cell Receptors Isolated from Patient Tumors Recognizing Wild-Type Antigens and Potent Peptide Mimotopes | 2020-12-17 |
20200392202 | PDL2 COMPOUNDS | 2020-12-17 |
20200392203 | IMMUNOTHERAPY AGAINST TRANSFERRIN RECEPTOR 1 (TFR1)-TROPIC ARENAVIRUSES | 2020-12-17 |
20200392204 | DARIC INTERLEUKIN RECEPTORS | 2020-12-17 |
20200392205 | MUTEINS OF CLOTTING FACTOR Vlll | 2020-12-17 |
20200392206 | ALBUMIN VARIANTS AND CONJUGATES | 2020-12-17 |
20200392207 | NOVEL POLYPEPTIDES AND MEDICAL USES THEREOF | 2020-12-17 |
20200392208 | CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS (HSV) RELATED KERATITIS | 2020-12-17 |
20200392209 | STABILIZED LIQUID ANTI-RSV ANTIBODY FORMULATIONS | 2020-12-17 |
20200392210 | ANTI-PCRV ANTIBODIES THAT BIND PCRV, COMPOSITIONS COMPRISING ANTI-PCRV ANTIBODIES, AND METHODS OF USE THEREOF | 2020-12-17 |
20200392211 | METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS | 2020-12-17 |
20200392212 | IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS | 2020-12-17 |
20200392213 | COMPOSITIONS AND METHODS FOR TREATING HIF-1a OVER-EXPRESSING CANCERS | 2020-12-17 |
20200392214 | METHOD FOR THE PRODUCTION OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | 2020-12-17 |
20200392215 | ANGIOPOIETIN-LIKE 4 ANTIBODIES AND METHODS OF USE | 2020-12-17 |
20200392216 | TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT | 2020-12-17 |
20200392217 | HUMAN-DERIVED ANTI-HUNTINGTIN (HTT) ANTIBODIES AND USES THEREOF | 2020-12-17 |
20200392218 | COMPOSITIONS AND METHODS FOR REDUCING AT LEAST ONE SYMPTOM OF HUMAN ALLERGY TO CATS | 2020-12-17 |
20200392219 | EXTRACELLULAR VESICLES COMPRISING MEMBRANE-TETHERED TGF-BETA, COMPOSITIONS AND METHODS OF USE THEREOF | 2020-12-17 |
20200392220 | ANTIBODY FORMULATION | 2020-12-17 |
20200392221 | TGF-BETA 3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF | 2020-12-17 |
20200392222 | IL-18 BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES | 2020-12-17 |
20200392223 | IL-17A ACTIVITY INHIBITOR AND USE THEREOF | 2020-12-17 |
20200392224 | METHODS FOR TREATING SYSTEMIC SCLEROSIS | 2020-12-17 |
20200392225 | NATRIURETIC PEPTIDE RECEPTOR 1 ANTIBODIES AND METHODS OF USE | 2020-12-17 |
20200392226 | ENZYMATIC MODIFICATION OF ANTI-AQP4 AUTOANTIBODY FOR MODULATING NEUROMYELITIS OPTICA | 2020-12-17 |
20200392227 | THERAPEUTIC AGENTS AND METHODS FOR ENHANCING IMMUNE RESPONSES IN TUMOR MICROENVIRONMENT | 2020-12-17 |